Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.

Discussion Lenalidomide is a therapeutic option for thalidomide-refractory patients with POEMS syndrome. PMID: 32009091 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32009091?dopt=Abstract

Source: Internal Medicine - February 6, 2020 Category: Internal Medicine Tags: Intern Med Source Type: research

More News: Clinical Trials | Dexamethasone | Internal Medicine | Revlimid | Skin